Patents by Inventor Inbal ITZHAK

Inbal ITZHAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A3 adenosine receptor ligand for use for achieving a fat loss effect
    Patent number: 12213990
    Abstract: Provided is an A3 adenosine receptor (A3AR) ligand for use in achieving at least one fat loss effect selected from: reducing weight of the subject; reducing body fat mass in the subject; treating obesity in the subject and inhibiting adipocytes proliferation in a subject. The disclosure also concerns pharmaceutical compositions, methods of treatment and kits comprising the A3AR ligand.
    Type: Grant
    Filed: January 5, 2020
    Date of Patent: February 4, 2025
    Assignee: CAN-FITE BIOPHARMA LTD.
    Inventors: Motti Farbstein, Inbal Itzhak, Shira Cohen, Pnina Fishman
  • CANNABINOIDS FOR USE IN TREATMENT
    Publication number: 20230049415
    Abstract: Cannabinoids are used to treat diseases or disorders treatable by an activator of the A3 adenosine receptor (A3AR). The cannabinoid effect is exerted through the A3AR. The cannabinoids may be selected from natural, phytocannabinoids, synthetic derivatives of phytocannabinoids, extracts of cannabis plant, and others.
    Type: Application
    Filed: January 14, 2021
    Publication date: February 16, 2023
    Applicant: CAN-FITE BIOPHARMA LTD.
    Inventors: Pnina FISHMAN, Inbal ITZHAK
  • AN A3 ADENOSINE RECEPTOR LIGAND FOR USE FOR ACHIEVING A FAT LOSS EFFECT
    Publication number: 20220079968
    Abstract: Provided is an A3 adenosine receptor (A3AR) ligand for use in achieving at least one fat loss effect selected from: reducing weight of the subject; reducing body fat mass in the subject; treating obesity in the subject and inhibiting adipocytes proliferation in a subject. The disclosure also concerns pharmaceutical compositions, methods of treatment and kits comprising the A3AR ligand.
    Type: Application
    Filed: January 5, 2020
    Publication date: March 17, 2022
    Applicant: CAN-FITE BIOPHARMA LTD.
    Inventors: Motti FARBSTEIN, Inbal ITZHAK, Shira COHEN, Pnina FISHMAN